Stock ANGN ANGN BIOM
Add to a list
To use this feature you must be a member
Log inSign up

Other languages ANGN BIOM

Equities

ANGN

US03476J1079

Market Closed - Nasdaq
Other stock markets
 21:30:01 03/05/2024 BST 		5-day change 1st Jan Change
8.98 USD -0.22% Intraday chart for ANGN BIOM -0.11% -10.20%
2023 Angion Biomedica Corp. Announces Resignation of Assaf Segal from Its Board of Directors CI
2023 Angion Biomedia to Implement 10-for-1 Reverse Split MT

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Angion Biomedica Corp. Announces Resignation of Assaf Segal from Its Board of Directors
Angion Biomedia to Implement 10-for-1 Reverse Split
Elicio Therapeutics, Inc. completed the acquisition of Angion Biomedica Corp. from Vifor (International) AG, Eisa-Abc LLC and others in a reverse merger transaction.
Angion Biomedica Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023
Sector Update: Health Care Stocks Finishing Near Intra-Day Lows
Sector Update: Health Care Stocks Sputtering in Tuesday Trading
Top Midday Decliners
Investors Digest More Big Bank Earnings, Weighing on US Equity Futures
Top Premarket Decliners
Angion Biomedica Agrees to Merge With Elicio Therapeutics
Angion Biomedica Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
Angion Biomedica Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
Earnings Flash (ANGN) ANGION BIOMEDICA Posts Q2 Revenue $653,000
Angion Announces Process to Explore Strategic Alternatives for Enhancing and Preserving Shareholder Value
Angion Biomedica Corp. Announces Resignation of John F. Neylan as Chief Medical Officer and Head of Research, Effective on August 15, 2022
Sector Update: Health Care Stocks Little Changed on Thursday
Sector Update: Health Care
Angion Biomedica Corp. Announces Discontinuation of Phase 2 Trial of ANG-3070 in Patients with Primary Proteinuric Kidney Disease
Angion Biomedica Files $100 Million Mixed Shelf
Angion Biomedica Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ANGN Stock
  4. News ANGN BIOM
  5. Other languages